Insiders · FHTX

Scott Biller

Director at Foghorn Therapeutics Inc. (FHTX)

Scott Biller has filed 6 insider reports with the SEC since July 2021, as director at Foghorn Therapeutics Inc. (FHTX). The latest filing, on June 25, 2026, reports grant or award at Foghorn Therapeutics Inc. (FHTX).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Scott Biller is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Foghorn Therapeutics Inc. logo
FHTX
Foghorn Therapeutics Inc.
Director$1.72Jun 25, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Scott Biller with

Other insiders at the same companies

Questions about Scott Biller

What is Scott Biller's role at Foghorn Therapeutics Inc.?
Scott Biller reports to the SEC as director at Foghorn Therapeutics Inc. (FHTX), according to the latest filing on June 25, 2026.
Has Scott Biller bought or sold stock recently?
No open-market purchases or sales by Scott Biller are on file. The filings report grant or award.
How do I get alerts when Scott Biller files?
Follow Scott Biller on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Scott Biller (SEC CIK 0001581956). Totals count each trade once, skipping amendments whose original is on file, from Jul 14, 2021 on. View on SEC EDGAR · Get this as JSON